Correlation Between Rezolute and Zentalis Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Rezolute and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rezolute and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rezolute and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Rezolute and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rezolute with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rezolute and Zentalis Pharmaceuticals.

Diversification Opportunities for Rezolute and Zentalis Pharmaceuticals

0.19

Correlation Coefficient

Rezolute  Zentalis Pharmaceuticals

Average diversification

The 3 months correlation between Rezolute and Zentalis is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Rezolute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rezolute are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Rezolute i.e., Rezolute and Zentalis Pharmaceuticals go up and down completely randomly.

Pair Corralation between Rezolute and Zentalis Pharmaceuticals

Given the investment horizon of 90 days Rezolute is expected to generate 1.49 times less return on investment than Zentalis Pharmaceuticals. But when comparing it to its historical volatility, Rezolute is 1.86 times less risky than Zentalis Pharmaceuticals. It trades about 0.33 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest  296.00  in Zentalis Pharmaceuticals Llc on August 14, 2024 and sell it today you would earn a total of  107.00  from holding Zentalis Pharmaceuticals Llc or generate 36.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Rezolute  vs.  Zentalis Pharmaceuticals Llc

Rezolute

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Rezolute are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Rezolute unveiled solid returns over the last few months and may actually be approaching a breakup point.

Zentalis Pharmaceuticals

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Zentalis Pharmaceuticals Llc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Zentalis Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Rezolute and Zentalis Pharmaceuticals

The main advantage of trading using opposite Rezolute and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rezolute position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.

The idea behind Rezolute and Zentalis Pharmaceuticals Llc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.